Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
AVTX holding history
Avalo Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 323,833
- Value
- $5.98M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 323,833 | $5.98M | <0.1% | +130,098+67.2% | Added | Holders |
| Q1 2026 | 193,735 | $2.89M | <0.1% | −225,756−53.8% | Reduced | Holders |
| Q4 2025 | 419,491 | $7.62M | <0.1% | −62,178−12.9% | Reduced | Holders |
| Q3 2025 | 481,669 | $6.12M | <0.1% | +481,669 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −7,414−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q2 2022 | 88,974 | $44.0K | <0.1% | +59,815+205.1% | Added | Holders |
| Q1 2022 | 29,159 | $22.0K | <0.1% | −33,769−53.7% | Reduced | Holders |
| Q4 2021 | 62,928 | $107.0K | <0.1% | +31,769+102.0% | Added | Holders |
| Q3 2021 | 31,159 | $68.0K | <0.1% | +6,895+28.4% | Added | Holders |
| Q2 2021 | 24,264 | $79.0K | <0.1% | +24,264 | New | Holders |